The recommendations are similar to those recently announced for TTVR, with the final NCD for T-TEER expected by July.

The “passive” notification led to more patients with severe AS undergoing valve replacement, but more can be done still.

While inconsistent dosing could have played a role, it still may be possible to identify the patients most likely to see ...

The follow-up brought little surprise, with investigators pleased the risk of death/disabling stroke remained on par with ...

Sammy Elmariah, MD, MPH, and David Playford, MD, PhD discuss the ways technology and AI can be used to assist in better treatment and diagnosis of severe aortic stenosis.

Nurse-led efforts to provide patients with ongoing lifestyle advice, education, and other resources reduced MACE by 30%.

LV thrombus is less of an issue now thanks to primary PCI and antithrombotics, but it still occurs in 9% of anterior MIs.

Experts are dismayed, disappointed, and confused, but many say this isn’t the end of cerebral embolic protection for TAVI.

Liberal fluid intake was safe and suggestive of better health status: this should be enough to stop restricting patients to 1 ...

Cotemporary DES paired with FFR guidance and modern medical therapy may be what narrowed the gap, William Fearon says.

The prothrombin complex concentrate costs more than plasma, but may pay dividends by way of fewer adverse events.

Disappointment over a cardiology board, an FDA approval, meeting news, and advice for practice—it’s all here this month.